Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures
NCT02924844 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2787
Last updated 2016-10-05
Summary
The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.
Conditions
- Intensive Care
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
More Related Trials
-
Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive Care
NCT02127528 ·Status: UNKNOWN
-
Oral Care Layered Enhancement for Improved Oral Hygiene in Intensive Care Units
NCT07129733 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients
NCT00543894 ·Status: COMPLETED
-
PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
NCT03858387 ·Status: UNKNOWN
-
Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units
NCT03475238 ·Status: COMPLETED
-
Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
NCT01554657 ·Status: COMPLETED ·Phase: NA
-
Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage
NCT03927079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
NCT04937075 ·Status: COMPLETED
-
Anaerobic Antibiotic Usage for Pneumonia in the Medical Intensive Care Unit
NCT03046082 ·Status: COMPLETED
-
Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
NCT02728518 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
NCT04433325 ·Status: UNKNOWN
-
Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
NCT00861315 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Implementing Oral Care Bundle on Critical Care Nurses' Practice and Mechanically Ventilated Patients' Outcomes
NCT05351619 ·Status: UNKNOWN ·Phase: NA
-
Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients
NCT01495039 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital
NCT04318613 ·Status: COMPLETED
-
Ventilation Associated Pneumonia and Covid-19
NCT05089968 ·Status: COMPLETED
-
Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA)
NCT06243094 ·Status: RECRUITING
-
Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
NCT00431483 ·Status: COMPLETED ·Phase: NA
-
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
NCT03752476 ·Status: UNKNOWN
-
Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit
NCT01878643 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia
NCT06743529 ·Status: RECRUITING ·Phase: NA
-
Direct Molecular Characterization of Bacteria From ICU and From the REHAB
NCT03475472 ·Status: COMPLETED
-
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
NCT07052604 ·Status: RECRUITING
-
Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream Infections
NCT02891902 ·Status: COMPLETED
-
Impact of Antibio Prophylaxis on Occurence of Ventilator Associated Pneumonia in Trauma Patients
NCT07059039 ·Status: COMPLETED